WAC 246-945-034. Identification of the over-the-counter drugs

(1) The commission identifies the following as an over-the-counter drug in Washington: (a) 4 mg naloxone hydrochloride nasal spray, approved by the FDA for marketing as an OTC drug product. (b) 3 mg naloxone hydrochloride nasal spray, approved by the FDA for marketing as an OTC drug product. (2) Any conflicts between this section and the publications incorporated by reference in WAC 246-945-030 (2) should be resolved in favor of this section.